CT.gov Strict-Core Black-Box
2026-03-29 | full-registry ct.gov audit | plots, figures, and e156 bundle
Series
IndustrySponsor-ClassPhaseStructural MissingnessEvidence VisibilityCompletion CohortCondition HiddennessSponsor ConcentrationRule-Era ReportingPublication UndercountOncology HiddennessCardiovascular HiddennessMetabolic HiddennessEnrollment-SizeGeography-ScaleDesign-PurposeCompletion-DelayTrial-ArchitectureIntervention-TypeCountry ReportingStopped-TrialOutcome-DensityActual-FieldUs-Versus-GlobalModality-SponsorCountry-ConditionDisease-GeographyCondition-SponsorCountry-SponsorUs-Versus-Ex-UsIndustry-FamilyRisk-Adjusted HiddennessOverdue Results ClockPublication Index GapProbable Act/Fdaaa DebtSponsor Excess WatchlistCountry Excess WatchlistCondition Excess WatchlistBlack-Box TrialsStrict-Proxy RepeatersSponsor GhostsCountry GhostsCondition GhostsBlack-Box SponsorsStrict Black-Box
Strict Black-Box Dashboard

Strict-core black-box tables show that the regulated-looking deep-silence subset remains heavily concentrated in industry portfolios

Industry carries the largest strict-core black-box stock, Bayer leads the named strict-core table, Novartis and Bristol-Myers Squibb remain close behind, and NETWORK stays worse on broad no-results rate than on black-box stock.

Open dashboardRead E156 paperProtocolSeries hub
Named stock
Class stock
Class rates
Strict core

Dashboard

Open dashboard at rootRead E156 micro-paperOpen protocolOpen series hub

Industry holds 3,001 strict-core black-box studies, Bayer leads the named table at 122, Novartis and Bristol-Myers Squibb follow, and NETWORK remains worse on overall no-results rate than on black-box stock.

How to read the dashboard
Industry box
3,001
Class stock
Bayer box
122
Named stock
Bristol box
81
Third named stock
Other box
1,385
Other class stock
Strict-core named black-box stock
NAMED BLACK-BOX STOCKTop named sponsor black-box counts inside the strict U.S.-nexus coreBayer122Novartis Pharmaceuticals82BMS81Roxane Laboratories79GlaxoSmithKline79Hoffmann-La Roche73Pfizer70Sanofi63Alcon Research55AstraZeneca54
Bayer, Novartis, Bristol-Myers Squibb, Roxane Laboratories, and GlaxoSmithKline lead the named strict-core black-box table.
This subset is more concentrated than the broader strict-core missing-results table.
Strict-core class black-box stock
CLASS BLACK-BOX STOCKStrict-core black-box study counts by sponsor classINDUSTRY3,001OTHER1,385FED46NIH24NETWORK17INDIV12OTHER_GOV2UNKNOWN0
Industry dominates strict-core black-box stock, with OTHER a distant second and all other classes much smaller.
The regulated-looking deep-silence stock is therefore heavily class-concentrated.
Strict-core class no-results rate
CLASS NO-RESULTS RATEStrict-core missing-results rate by sponsor classOTHER_GOV64.0%INDIV52.6%NETWORK48.8%FED39.2%NIH33.3%INDUSTRY31.0%OTHER31.0%UNKNOWN9.1%
NETWORK is the sharpest class on broad no-results rate even though industry dominates the strict-core black-box stock table.
The rate and stock views identify different kinds of strict-core risk.
Read Across Projects

Across The Series

Each project isolates a different dimension of registry opacity, but the point is the contrast between them, not a single leaderboard.

Industry
Industry project

Industry project from the CT.gov hiddenness series.

Sponsor-Class
Sponsor-class project

Sponsor-class project from the CT.gov hiddenness series.

Phase
Phase project

Phase project from the CT.gov hiddenness series.

Structural Missingness
Structural missingness project

Structural missingness project from the CT.gov hiddenness series.

Evidence Visibility
Evidence visibility project

Evidence visibility project from the CT.gov hiddenness series.

Completion Cohort
Completion cohort project

Completion cohort project from the CT.gov hiddenness series.

Condition Hiddenness
Condition hiddenness project

Condition hiddenness project from the CT.gov hiddenness series.

Sponsor Concentration
Sponsor concentration project

Sponsor concentration project from the CT.gov hiddenness series.

Rule-Era Reporting
Rule-era reporting project

Rule-era reporting project from the CT.gov hiddenness series.

Publication Undercount
Publication undercount audit

Publication undercount audit from the CT.gov hiddenness series.

Oncology Hiddenness
Oncology hiddenness project

Oncology hiddenness project from the CT.gov hiddenness series.

Cardiovascular Hiddenness
Cardiovascular hiddenness project

Cardiovascular hiddenness project from the CT.gov hiddenness series.

Metabolic Hiddenness
Metabolic hiddenness project

Metabolic hiddenness project from the CT.gov hiddenness series.

Enrollment-Size
Enrollment-size project

Enrollment-size project from the CT.gov hiddenness series.

Geography-Scale
Geography-scale project

Geography-scale project from the CT.gov hiddenness series.

Design-Purpose
Design-purpose project

Design-purpose project from the CT.gov hiddenness series.

Completion-Delay
Completion-delay project

Completion-delay project from the CT.gov hiddenness series.

Trial-Architecture
Trial-architecture project

Trial-architecture project from the CT.gov hiddenness series.

Intervention-Type
Intervention-type project

Intervention-type project from the CT.gov hiddenness series.

Country Reporting
Country reporting project

Country reporting project from the CT.gov hiddenness series.

Stopped-Trial
Stopped-trial project

Stopped-trial project from the CT.gov hiddenness series.

Outcome-Density
Outcome-density project

Outcome-density project from the CT.gov hiddenness series.

Actual-Field
Actual-field project

Actual-field project from the CT.gov hiddenness series.

Us-Versus-Global
US-versus-global project

US-versus-global project from the CT.gov hiddenness series.

Modality-Sponsor
Modality-sponsor project

Modality-sponsor project from the CT.gov hiddenness series.

Country-Condition
Country-condition project

Country-condition project from the CT.gov hiddenness series.

Disease-Geography
Disease-geography project

Disease-geography project from the CT.gov hiddenness series.

Condition-Sponsor
Condition-sponsor project

Condition-sponsor project from the CT.gov hiddenness series.

Country-Sponsor
Country-sponsor project

Country-sponsor project from the CT.gov hiddenness series.

Us-Versus-Ex-Us
US-versus-ex-US project

US-versus-ex-US project from the CT.gov hiddenness series.

Industry-Family
Industry-family project

Industry-family project from the CT.gov hiddenness series.

Risk-Adjusted Hiddenness
Risk-adjusted hiddenness

Risk-adjusted hiddenness from the CT.gov hiddenness series.

Overdue Results Clock
Overdue results clock

Overdue results clock from the CT.gov hiddenness series.

Publication Index Gap
Publication index gap

Publication index gap from the CT.gov hiddenness series.

Probable Act/Fdaaa Debt
Probable ACT/FDAAA debt

Probable ACT/FDAAA debt from the CT.gov hiddenness series.

Sponsor Excess Watchlist
Sponsor excess watchlist

Sponsor excess watchlist from the CT.gov hiddenness series.

Country Excess Watchlist
Country excess watchlist

Country excess watchlist from the CT.gov hiddenness series.

Condition Excess Watchlist
Condition excess watchlist

Condition excess watchlist from the CT.gov hiddenness series.

Black-Box Trials
Black-box trials

Black-box trials from the CT.gov hiddenness series.

Strict-Proxy Repeaters
Strict-proxy repeaters

Strict-proxy repeaters from the CT.gov hiddenness series.

Sponsor Ghosts
CT.gov Sponsor Ghost Repeaters

Named-sponsor ghost-protocol watchlist showing which sponsors remain most ghosted above expectation.

Country Ghosts
CT.gov Country Ghost Watchlist

Country-linked ghost watchlist showing where deeper silence remains most elevated above expectation.

Condition Ghosts
CT.gov Condition Ghost Watchlist

Condition-family ghost watchlist showing which therapeutic portfolios are ghosted well above expectation.

Black-Box Sponsors
CT.gov Black-Box Sponsor Repeaters

Named-sponsor black-box tables showing where no-results, no-paper, no-description silence concentrates.

Source on GitHub | Project home | Dashboard